No Pain More Gain

Description

NPMG Sport Strength is a pharmaceutical formulation designed for athletic performance enhancement. It is characterized by its specific composition aimed at supporting physical strength and endurance. The product is presented in a dosage form suitable for athletes, ensuring optimal absorption and efficacy. The formulation's appearance is consistent with industry standards for performance supplements, facilitating ease of use and integration into athletic regimens.

Uses and Indications

NPMG Sport Strength is indicated for individuals engaged in bodybuilding and strength-related sports. This product is optimized to enhance performance as a superior pre-and post-workout spray, specifically designed to facilitate muscle building and accelerate strength gains.

This formulation is endorsed by physiotherapists, underscoring its suitability for athletes seeking to improve their physical capabilities.

There are no teratogenic or nonteratogenic effects associated with this product.

Dosage and Administration

Healthcare professionals are advised to instruct patients to shake the product well before use. The recommended administration involves spraying the formulation onto the muscles both prior to and following physical workouts. It is essential to wait until the crackling effect subsides before proceeding with any further actions.

After application, the product should be gently massaged into the skin to ensure proper absorption. Following the application, patients must wash their hands thoroughly to prevent unintentional contact with sensitive areas.

The product may be applied up to 4 to 6 times per day, depending on individual needs. It is important to note that this product is not recommended for use in children under 12 years of age.

Contraindications

There are no specific contraindications listed for this product. However, it is advised to discontinue use and consult a healthcare professional if any of the following occur: worsening of the condition, skin irritation, or if symptoms persist for more than 7 days or resolve and then recur within a few days.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes and mucous membranes to prevent irritation or injury. The product should not be applied to irritated skin, as this may exacerbate the condition. Additionally, the treated area should not be wrapped, bandaged, or subjected to heat from a heating pad, as these actions may lead to increased absorption and potential adverse effects. The product is contraindicated for use on open wounds or broken skin.

Patients should be advised to discontinue use and contact their healthcare provider if any of the following occur: worsening of the condition, development of skin irritation, or if symptoms persist for more than 7 days. Furthermore, if symptoms resolve and then recur within a few days, medical consultation is recommended to assess the need for further evaluation or alternative treatment options.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. This product is intended for external use only and should not come into contact with the eyes or mucous membranes. It is contraindicated for use on irritated skin, open wounds, or broken skin. Additionally, patients should avoid wrapping, bandaging, or applying a heating pad to the treated area.

In clinical practice, patients are advised to discontinue use and consult a healthcare professional if any of the following occur: worsening of the condition, development of skin irritation, or if symptoms persist for more than 7 days. If symptoms resolve and then recur within a few days, it is also recommended to seek medical advice. These precautions are essential to ensure the safe and effective use of the product.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions between the drug and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of No Pain More Gain (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not be administered this medication. Safety and efficacy have not been established in this age group, and use is contraindicated. Healthcare professionals are advised to consider alternative treatments for pediatric patients within this age range.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. The potential risks and benefits should be carefully evaluated, and alternative treatments may be considered in consultation with the patient. Women of childbearing potential should be advised to discuss their pregnancy status and any plans for pregnancy with their healthcare provider prior to initiating treatment.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion or misuse.

Patients should be instructed to stop using the product and consult a doctor if any of the following occur: the condition worsens, skin irritation develops, or if symptoms persist for more than 7 days. Additionally, patients should be made aware that if symptoms clear up and then recur within a few days, they should also seek medical advice.

Storage and Handling

The product is supplied in a pressurized container, which requires careful handling to ensure safety and efficacy. It is essential to store the product in a cool, dry place, away from direct sunlight and any sources of heat. The recommended storage temperature should not exceed 120°F (49°C).

Users must avoid exposing the container to flames or hot surfaces, as this may lead to hazardous situations. Additionally, it is crucial to keep the product away from sources of ignition to prevent any risk of fire. The container should not be punctured or incinerated, as this could result in dangerous consequences.

When utilizing this product, it is advised to maintain a safe distance from the face and mouth to prevent inhalation of the aerosol. Proper adherence to these storage and handling guidelines will help ensure the safe use of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for No Pain More Gain, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)